Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
M	O
Service:	O
MEDICINE	O
Allergies:	O
Patient	O
recorded	O
as	O
having	O
No	O
Known	O
Allergies	O
to	O
Drugs	O
Attending:	O
___	O
Chief	O
Complaint:	O
Acute	O
Exacerbation	O
of	O
Congestive	O
Heart	O
Failure	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
central	O
line	O
placement	O
hemodialsys	O
catheter	O
placement	O
___	O
History	O
of	O
Present	O
Illness:	O
PCP:	O
___.	O
___,	O
521	O
___,	O
Suite	O
#202,	O
Briefly,	O
___	O
yo	O
male	O
with	O
Hx	O
of	O
ischemic	O
cardiomnypothy	O
s/p	O
CABG,	O
CHF	O
(EF	O
30%),	O
DM,	O
and	O
peripheral	O
vascular	O
disease	O
s/p	O
bipass	O
with	O
graft	O
on	O
left	O
femoral	O
artery	O
___	O
___.	O
Since	O
discharge	O
from	O
___	O
___	O
___,	O
he	O
did	O
not	O
take	O
any	O
of	O
his	O
CHF	O
meds,	O
and	O
now	O
returns	O
increased	O
swelling	O
___	O
his	O
abdomen,	O
legs.	O
Orthopnea,	O
+DOE	O
(can	O
only	O
walk	O
to	O
the	O
bathroom,	O
can	O
not	O
climb	O
a	O
flight	O
of	O
stairs	O
___	O
to	O
dyspnea)	O
as	O
well	O
as	O
50lbs	O
weight	O
gain	O
specially	O
over	O
the	O
last	O
week.	O
He	O
finally	O
came	O
back	O
to	O
ED	O
on	O
___	O
b/c	O
groin	O
abscess	O
and	O
was	O
initially	O
admitted	O
to	O
vascular	O
service.	O
The	O
abcess	O
was	O
drained	O
and	O
he	O
was	O
started	O
on	O
nafcillin	O
on	O
___.	O
He	O
was	O
then	O
transferred	O
to	O
___	O
for	O
diuresis	O
on	O
___.	O
On	O
the	O
floor,	O
he	O
was	O
started	O
on	O
a	O
lasix	O
gtt	O
(5	O
->	O
10	O
mg/hr)	O
with	O
50-100cc	O
output	O
___	O
24hrs.	O
He	O
was	O
given	O
one	O
dose	O
of	O
chlorthiazide	O
and	O
loaded	O
with	O
digoxin.	O
Creatinine	O
was	O
increased	O
to	O
3.9	O
from	O
baseline	O
of	O
1.5.	O
Renal	O
consulted	O
for	O
further	O
eval	O
of	O
oliguria.	O
Urology	O
also	O
following	O
because	O
he	O
was	O
having	O
urinary	O
retention.	O
___	O
placed	O
(and	O
then	O
replaced)	O
by	O
urology	O
but	O
still	O
not	O
draining	O
adequately.	O
He	O
was	O
given	O
one	O
dose	O
of	O
hyoscyamine	O
ungoing	O
bladder	O
spasm	O
and	O
per	O
urology	O
giving	O
but	O
can	O
exacerbate	O
tachycardia	O
(only	O
recived	O
one	O
dose)	O
Given	O
the	O
poor	O
response	O
to	O
lasix	O
gtt,	O
the	O
CHF	O
service	O
has	O
requested	O
transfer	O
to	O
CCU	O
for	O
pressors	O
(milrinone)	O
to	O
see	O
if	O
he	O
will	O
autodiurese	O
with	O
improved	O
cardiac	O
output.	O
Past	O
Medical	O
History:	O
#	O
CAD:	O
MI	O
___	O
s/p	O
CABG	O
2	O
vessels	O
___,	O
s/p	O
redo	O
CABG	O
5	O
vessels	O
#	O
CHF:	O
ischemic	O
cardiomyopathy,	O
LVEF	O
35%	O
by	O
PMIBI	O
___	O
#	O
atrial	O
fibrillation	O
on	O
coumadin	O
#	O
DM	O
type	O
2:	O
c/b	O
peripheral	O
neuropathy	O
#	O
hyperlipidemia	O
#	O
HTN	O
#	O
Anemia:	O
baseline	O
HCT	O
___	O
#	O
COPD:	O
no	O
PFTs	O
recently,	O
started	O
advair	O
1	O
month	O
ago	O
#	O
PVD:	O
s/p	O
redo	O
fem-fem	O
right	O
to	O
AK-popliteal	O
with	O
8-mm	O
PFT	O
and	O
right	O
___	O
toe	O
amputation	O
on	O
___	O
s/p	O
right	O
femoral	O
BK-popliteal	O
bypass	O
with	O
PTFE	O
on	O
___.	O
L	O
Fem-Pop	O
w/	O
PTFE	O
and	O
___	O
L	O
toe	O
amputation	O
___	O
#	O
s/p	O
Aortobifemoral	O
bypass	O
graft	O
for	O
abdominal	O
aortic	O
aneurysm	O
___	O
#	O
colon	O
polyps	O
s/p	O
polypectomy	O
#	O
internal	O
hemorrhoids	O
Cardiac	O
Risk	O
Factors:	O
+	O
Diabetes,	O
+	O
Dyslipidemia,	O
+	O
Hypertension	O
Social	O
History:	O
___	O
Family	O
History:	O
Non-contributory	O
Physical	O
Exam:	O
T	O
96.3,	O
Bp	O
84/37,	O
RR	O
16	O
Hr	O
82	O
Afib	O
,	O
Sat	O
100%	O
General:	O
non	O
apparent	O
distress,	O
HEENt:	O
dry	O
oral	O
mucose,	O
NO	O
LAD.	O
JVD	O
up	O
to	O
the	O
earlobe	O
at	O
45	O
degrees	O
Lungs:	O
few	O
crackles	O
___	O
the	O
bases.	O
CV:	O
irregularly	O
irregular.	O
s1-s2	O
normal,	O
?	O
s3.	O
holosytolic	O
murmur	O
RLSB	O
Abdomen:	O
Distended,	O
BS	O
decreased,	O
+	O
ascitis.	O
Non	O
tender.	O
Extremities	O
3+	O
edema	O
up	O
to	O
the	O
thigh.	O
___	O
and	O
___	O
toe	O
amputated	O
L	O
and	O
R.	O
Distal	O
pulses	O
difficult	O
to	O
palpate	O
given	O
extensive	O
fluid	O
accumulation.	O
extremities	O
warm.	O
L	O
groin	O
wound-	O
gauze	O
___	O
place.	O
no	O
secretions.	O
mild	O
erythema.	O
L	O
thigh	O
wound-	O
no	O
secretion	O
either.	O
R	O
arm:	O
mild	O
erythmea	O
forearm.	O
Neuro:	O
Alert,	O
oriented.	B-Delirium
responding	O
appropiately	O
to	O
all	O
questions.	O
Pertinent	O
Results:	O
___	O
07:40AM	O
BLOOD	O
WBC-9.8	O
RBC-3.46*	O
Hgb-9.5*	O
Hct-29.7*	O
MCV-86	O
MCH-27.5	O
MCHC-32.1	O
RDW-15.6*	O
Plt	O
___	O
___	O
07:50AM	O
BLOOD	O
WBC-14.0*	O
RBC-2.60*	O
Hgb-6.9*	O
Hct-21.8*	O
MCV-84	O
MCH-26.7*	O
MCHC-31.8	O
RDW-17.8*	O
Plt	O
___	O
___	O
11:35PM	O
BLOOD	O
WBC-11.0	O
RBC-3.84*	O
Hgb-10.5*	O
Hct-31.7*	O
MCV-83	O
MCH-27.2	O
MCHC-32.9	O
RDW-16.5*	O
Plt	O
___	O
___	O
04:00PM	O
BLOOD	O
Neuts-84.3*	O
Lymphs-8.6*	O
Monos-5.7	O
Eos-0.8	O
Baso-0.5	O
___	O
06:28AM	O
BLOOD	O
___	O
PTT-35.2*	O
___	O
___	O
05:51AM	O
BLOOD	O
___	O
PTT-53.7*	O
___	O
___	O
11:35PM	O
BLOOD	O
___	O
PTT-40.1*	O
___	O
___	O
04:50PM	O
BLOOD	O
ESR-50*	O
___	O
11:30AM	O
BLOOD	O
Ret	O
Aut-2.6	O
___	O
07:40AM	O
BLOOD	O
Glucose-85	O
UreaN-48*	O
Creat-1.6*	O
Na-142	O
K-3.9	O
Cl-103	O
HCO3-28	O
AnGap-15	O
___	O
05:11AM	O
BLOOD	O
Glucose-44*	O
UreaN-83*	O
Creat-5.4*	O
Na-134	O
K-5.1	O
Cl-94*	O
HCO3-27	O
AnGap-18	O
___	O
11:35PM	O
BLOOD	O
Glucose-119*	O
UreaN-52*	O
Creat-1.7*	O
Na-138	O
K-2.8*	O
Cl-96	O
HCO3-32	O
AnGap-13	O
___	O
05:40AM	O
BLOOD	O
ALT-10	O
AST-27	O
AlkPhos-129*	O
Amylase-44	O
TotBili-1.0	O
DirBili-0.6*	O
IndBili-0.4	O
___	O
05:42AM	O
BLOOD	O
ALT-9	O
AST-26	O
LD(LDH)-184	O
AlkPhos-121*	O
TotBili-1.9*	O
___	O
03:17AM	O
BLOOD	O
CK(CPK)-334*	O
___	O
09:04PM	O
BLOOD	O
CK(CPK)-404*	O
___	O
05:40AM	O
BLOOD	O
Lipase-38	O
___	O
02:45PM	O
BLOOD	O
Lipase-34	O
___	O
03:17AM	O
BLOOD	O
CK-MB-3	O
cTropnT-0.19*	O
___	O
09:04PM	O
BLOOD	O
CK-MB-3	O
cTropnT-0.20*	O
___	O
02:45PM	O
BLOOD	O
CK-MB-4	O
cTropnT-0.20*	O
___	O
11:37AM	O
BLOOD	O
CK-MB-3	O
cTropnT-0.23*	O
___	O
07:40AM	O
BLOOD	O
Calcium-8.6	O
Phos-3.6	O
Mg-2.1	O
___	O
05:42AM	O
BLOOD	O
Albumin-3.2*	O
Calcium-8.6	O
Phos-3.6	O
Mg-2.2	O
___	O
05:42AM	O
BLOOD	O
Hapto-136	O
___	O
04:22AM	O
BLOOD	O
Hapto-271*	O
___	O
06:28PM	O
BLOOD	O
calTIBC-169*	O
Ferritn-393	O
TRF-130*	O
___	O
06:30AM	O
BLOOD	O
calTIBC-160*	O
VitB12-904*	O
Folate-18.4	O
Ferritn-343	O
TRF-123*	O
___	O
08:11PM	O
BLOOD	O
%HbA1c-5.8	O
___	O
06:30AM	O
BLOOD	O
Triglyc-52	O
HDL-29	O
CHOL/HD-2.8	O
LDLcalc-41	O
___	O
01:16PM	O
BLOOD	O
TSH-11*	O
___	O
04:50PM	O
BLOOD	O
T3-74*	O
Free	O
T4-1.1	O
ERYTHROPOIETIN	O
12.3	O
4.1-19.5	O
MU/ML	O
___	O
02:37PM	O
URINE	O
Color-Yellow	O
Appear-Hazy	O
Sp	O
___	O
___	O
02:37PM	O
URINE	O
Blood-SM	O
Nitrite-NEG	O
Protein-TR	O
Glucose-NEG	O
Ketone-NEG	O
Bilirub-NEG	O
Urobiln-NEG	O
pH-5.0	O
Leuks-TR	O
___	O
02:37PM	O
URINE	O
RBC-<1	O
/HPF	O
WBC-3	O
Bacteri-NONE	O
Yeast-NONE	O
Epi-<1	O
/HPF	O
___	O
02:37PM	O
URINE	O
RBC-<1	O
/HPF	O
WBC-3	O
Bacteri-NONE	O
Yeast-NONE	O
Epi-<1	O
/HPF	O
CULTURE	O
DATA:	O
URINE	O
CULTURE	O
(Final	O
___:	O
YEAST.	O
10,000-100,000	O
ORGANISMS/ML..	O
Blood	O
Culture,	O
Routine	O
(Final	O
___:	O
NO	O
GROWTH.	O
Blood	O
Culture,	O
Routine	O
(Final	O
___:	O
NO	O
GROWTH.	O
URINE	O
CULTURE	O
(Final	O
___:	O
NO	O
GROWTH.	O
URINE	O
CULTURE	O
(Final	O
___:	O
PSEUDOMONAS	O
AERUGINOSA.	O
>100,000	O
ORGANISMS/ML.	O
OF	O
TWO	O
COLONIAL	O
MORPHOLOGIES.	O
SENSITIVITIES:	O
MIC	O
expressed	O
___	O
MCG/ML	O
_________________________________________________________	O
PSEUDOMONAS	O
AERUGINOSA	O
|	O
CEFEPIME--------------	O
8	O
S	O
CEFTAZIDIME-----------	O
16	O
I	O
CIPROFLOXACIN---------	O
1	O
S	O
GENTAMICIN------------	O
<=1	O
S	O
IMIPENEM--------------	O
<=1	O
S	O
MEROPENEM-------------	O
1	O
S	O
PIPERACILLIN----------	O
32	O
S	O
PIPERACILLIN/TAZO-----	O
64	O
S	O
TOBRAMYCIN------------	O
<=1	O
S	O
GRAM	O
STAIN	O
(Final	O
___:	O
2+	O
___	O
per	O
1000X	O
FIELD):	O
POLYMORPHONUCLEAR	O
LEUKOCYTES.	O
2+	O
___	O
per	O
1000X	O
FIELD):	O
GRAM	O
POSITIVE	O
COCCI.	O
___	O
PAIRS	O
AND	O
CLUSTERS.	O
WOUND	O
CULTURE	O
(Final	O
___:	O
STAPH	O
AUREUS	O
COAG	O
+.	O
MODERATE	O
GROWTH.	O
Staphylococcus	O
species	O
may	O
develop	O
resistance	O
during	O
prolonged	O
therapy	O
with	O
quinolones.	O
Therefore,	O
isolates	O
that	O
are	O
initially	O
susceptible	O
may	O
become	O
resistant	O
within	O
three	O
to	O
four	O
days	O
after	O
initiation	O
of	O
therapy.	O
Testing	O
of	O
repeat	O
isolates	O
may	O
be	O
warranted.	O
SENSITIVITIES:	O
MIC	O
expressed	O
___	O
MCG/ML	O
_________________________________________________________	O
STAPH	O
AUREUS	O
COAG	O
+	O
|	O
CLINDAMYCIN-----------<=0.25	O
S	O
ERYTHROMYCIN----------<=0.25	O
S	O
GENTAMICIN------------	O
<=0.5	O
S	O
LEVOFLOXACIN----------	O
0.25	O
S	O
OXACILLIN-------------	O
0.5	O
S	O
PENICILLIN------------	O
=>0.5	O
R	O
TRIMETHOPRIM/SULFA----	O
<=0.5	O
S	O
Brief	O
Hospital	O
Course:	O
___	O
M	O
h/o	O
ischemic	O
CHF	O
(EF=25%),	O
1+MR,	O
3+TR,	O
DM,	O
PVD,	O
admitted	O
to	O
vascular	O
service	O
for	O
left	O
groin	O
abcess	O
s/p	O
___	O
fem-pop	O
bypass,	O
transferred	O
to	O
CCU	O
for	O
management	O
of	O
CHF,	O
with	O
acute	O
renal	O
failure	O
with	O
CVVH	O
for	O
volume	O
removal	O
then	O
transferred	O
to	O
the	O
floor	O
for	O
further	O
management.	O
Cardiovascular	O
1.Pump:	O
The	O
patient	O
has	O
Acute	O
on	O
chronic	O
systolic	O
CHF	O
-	O
he	O
has	O
ischemic	O
cardiomyopathy.	O
His	O
Last	O
Echo	O
___	O
showed	O
EF	O
20%-25%.	O
His	O
most	O
recent	O
cath	O
___	O
showed	O
patent	O
grafts,	O
no	O
interventions	O
done.	O
He	O
had	O
a	O
Lasix	O
drip	O
which	O
was	O
attempted	O
prior	O
to	O
transfer	O
to	O
CCU	O
with	O
no	O
significant	O
response.	O
On	O
transfer	O
to	O
the	O
CCU,	O
he	O
was	O
given	O
low	O
dose	O
milrinone	O
x3	O
days,	O
with	O
gross	O
anasarca	O
and	O
oliguric	O
renal	O
failure,	O
likely	O
secondary	O
to	O
CHF	O
per	O
renal,	O
though	O
he	O
did	O
have	O
proteinuria.	O
He	O
had	O
a	O
swan	O
placed	O
on	O
___,	O
milrinone	O
was	O
stopped,	O
and	O
his	O
CI	O
and	O
SVR	O
___	O
initially	O
concerning	O
for	O
septic	O
shock	O
8h	O
after	O
milrinone	O
was	O
stopped,	O
though	O
SBPs	O
stablized	O
off	O
milrinone	O
at	O
SBP	O
120s	O
and	O
on	O
CVVH.	O
The	O
pt	O
received	O
CVVH	O
___	O
with	O
net	O
27L	O
removed.	O
Lasix	O
drip	O
was	O
then	O
started	O
on	O
___	O
with	O
low	O
urine	O
output.	O
Diuril	O
was	O
added	O
Q12H	O
hr	O
with	O
improved	O
urine	O
output.	O
Renal	O
continued	O
to	O
follow	O
the	O
patient	O
and	O
he	O
never	O
required	O
hemodialysis.	O
The	O
patient	O
was	O
continued	O
on	O
a	O
lasix	O
gtt	O
on	O
the	O
floor	O
with	O
a	O
net	O
negative	O
goal	O
of	O
approximately	O
2L	O
a	O
day,	O
which	O
he	O
maintained	O
on	O
the	O
lasix	O
gtt	O
and	O
the	O
diuril	O
IV	O
BID.	O
He	O
continued	O
to	O
have	O
good	O
diuresis,	O
and	O
he	O
was	O
eventually	O
switched	O
to	O
Lasix	O
IV	O
TID,	O
then	O
BID.	O
He	O
was	O
transitioned	O
to	O
PO	O
lasix	O
prior	O
to	O
discharge	O
to	O
rehab.	O
His	O
edema	O
had	O
markedly	O
improved,	O
and	O
his	O
pulmonary	O
exam	O
was	O
improved	O
as	O
well.	O
His	O
O2	O
sats	O
were	O
>95%	O
on	O
room	O
air.	O
On	O
___,	O
the	O
patient	O
became	O
hypotensive	O
with	O
systolics	O
___	O
the	O
___.	O
His	O
WBC	O
count	O
had	O
increased	O
to	O
14,	O
but	O
he	O
remained	O
afebrile	O
without	O
any	O
clear	O
source	O
of	O
infection.	O
A	O
CT	O
abdomen/pelvis	O
was	O
done	O
for	O
a	O
slowly	O
decreasing	O
HCT	O
which	O
showed	O
bilateral,	O
but	O
right	O
greater	O
than	O
left	O
psoas	O
hematoma.	O
It	O
was	O
unclear	O
whether	O
there	O
was	O
active	O
bleeding	O
since	O
the	O
scan	O
was	O
done	O
without	O
contrast	O
given	O
his	O
renal	O
failure.	O
He	O
was	O
transferred	O
to	O
the	O
CCU	O
for	O
hypotension	O
and	O
workup	O
of	O
possible	O
sepsis/cardiogenic	O
shock.	O
___	O
the	O
CCU,	O
the	O
had	O
him	O
on	O
levophen	O
shortly	O
for	O
shock.	O
It	O
was	O
unclear	O
whether	O
this	O
was	O
cardiogenic	O
vs	O
septic,	O
but	O
he	O
was	O
started	O
and	O
maintained	O
on	O
Zosyn	O
with	O
improvement	O
___	O
his	O
leukocytosis	O
and	O
his	O
blood	O
pressure.	O
He	O
was	O
weaned	O
off	O
the	O
pressors,	O
and	O
his	O
metoprolol	O
was	O
up-titrated	O
with	O
good	O
response.	O
He	O
was	O
transferred	O
back	O
to	O
the	O
floor	O
where	O
he	O
remained	O
stable,	O
with	O
normal	O
BP,	O
afebrile,	O
and	O
improving	O
leukocytosis.	O
He	O
will	O
need	O
to	O
continue	O
lasix	O
PO,	O
as	O
well	O
as	O
Toprol	O
for	O
his	O
heart	O
failure.	O
He	O
will	O
also	O
continue	O
low	O
dose	O
ACE-I	O
with	O
uptitration	O
as	O
tolerated	O
by	O
his	O
creatinine.	O
At	O
the	O
time	O
of	O
discharge,	O
he	O
had	O
mild	O
crackles	O
at	O
the	O
lower	O
bases	O
and	O
will	O
likely	O
need	O
continue	O
his	O
lasix	O
for	O
a	O
goal	O
of	O
even	O
to	O
net	O
negative	O
500	O
cc	O
a	O
day.	O
#	O
Cardiac	O
-	O
ischemia:	O
The	O
patient	O
has	O
a	O
history	O
of	O
CAD.	O
He	O
is	O
s/p	O
CABG	O
___,	O
no	O
evidence	O
of	O
ischemia	O
currently.	O
He	O
will	O
need	O
to	O
continue	O
ASA	O
325	O
mg	O
daily,	O
Toprol,	O
Rosuvastatin,	O
and	O
Lisinopril.	O
#	O
cardiac	O
-	O
rhythm:	O
The	O
patient	O
initially	O
___	O
afib	O
with	O
HR	O
___	O
the	O
___.	O
He	O
received	O
a	O
dig	O
load	O
but	O
then	O
the	O
digoxin	O
was	O
stopped.	O
He	O
had	O
a	O
subtherapeutic	O
INR,	O
which	O
then	O
became	O
supratherapeutic,	O
and	O
the	O
warfarin	O
was	O
held.	O
His	O
metoprolol	O
was	O
up-titrated	O
for	O
improved	O
HR	O
control.	O
___	O
the	O
beginning	O
of	O
___,	O
the	O
patient	O
developed	O
bilateral,	O
spontaneous,	O
psoas	O
hematomas	O
with	O
a	O
decreasing	O
HCT.	O
The	O
heparin	O
drip	O
was	O
stopped,	O
and	O
the	O
warfarin	O
was	O
stopped	O
as	O
well.	O
This	O
is	O
presumed	O
anti-coagulation	O
failure	O
with	O
spontanous	O
life	O
threatening	O
bleeding,	O
and	O
given	O
his	O
high	O
risk	B-Falls
for	B-Falls
fall	B-Falls
as	O
well,	O
he	O
should	O
not	O
be	O
on	O
anti-coagulation	O
unless	O
later,	O
his	O
PCP	O
or	O
___	O
feels	O
another	O
trial	O
of	O
anticoagulation	O
should	O
be	O
initiated	O
to	O
decrease	O
his	O
risk	O
of	O
stroke	O
(high	O
given	O
age,	O
DM,	O
CHF).	O
He	O
will	O
need	O
to	O
continue	O
the	O
Toprol	O
and	O
ASA	O
325	O
mg	O
daily.	O
#	O
Acute	O
renal	O
failure	O
-	O
The	O
patient's	O
baseline	O
creaitnine	O
per	O
OMR	O
was	O
1.0-1.2.	O
During	O
this	O
hospitalization,	O
he	O
increaed	O
up	O
to	O
5.2	O
with	O
oliguria	O
thought	O
to	O
be	O
due	O
to	O
poor	O
forward	O
flow	O
from	O
his	O
heart	O
faliure.	O
He	O
had	O
a	O
foley	O
placed,	O
and	O
had	O
blood	O
clots	O
so	O
he	O
had	O
bladder	O
irrigation	O
as	O
well.	O
He	O
was	O
followed	O
by	O
urology	O
initially	O
for	O
the	O
hematuria	O
which	O
grossly	O
resolved.	O
The	O
patient	O
had	O
CVVH	O
for	O
a	O
few	O
days	O
while	O
___	O
the	O
CCU	O
for	O
volume	O
removal	O
given	O
the	O
poor	O
UOP	O
and	O
elevated	O
creatinine.	O
Renal	O
followed	O
closely,	O
and	O
he	O
was	O
initially	O
on	O
phosphate	O
binders.	O
At	O
the	O
time	O
of	O
discharge,	O
his	O
creatinine	O
had	O
improved	O
to	O
1.6.	O
He	O
will	O
have	O
followup	O
with	O
Dr.	O
___	O
___	O
___	O
___.	O
He	O
also	O
developed	O
a	O
UTI	B-Urinary_tract_infection
with	O
pseudomonas	O
which	O
was	O
treated	O
with	O
Cipro	O
for	O
14	O
days.	O
His	O
repeat	O
urine	O
cultures	O
only	O
grew	O
yeast,	O
but	O
no	O
UTI	B-Urinary_tract_infection
on	O
UA.	O
The	O
patient	O
will	O
be	O
discharged	O
with	O
a	O
foley,	O
and	O
while	O
at	O
rehab	O
should	O
have	O
bladder	O
training	O
to	O
eventually	O
remove	O
the	O
foley.	O
#	O
Left	O
groin	O
abcess	O
and	O
recent	O
RUE	O
cellulitis.	O
The	O
patient	O
had	O
a	O
Cefazolin	O
course	O
which	O
was	O
completed	O
on	O
___.	O
Vascular	O
surgery	O
followed	O
the	O
patient,	O
and	O
his	O
left	O
groin	O
abscess	O
improved.	O
He	O
was	O
followed	O
by	O
wound	O
care	O
with	O
their	O
recommendations.	O
He	O
should	O
continue	O
to	O
have	O
wound	O
care	O
while	O
he	O
is	O
___	O
rehab.	O
Also,	O
he	O
will	O
follow	O
up	O
with	O
Dr.	O
___	O
discharge	O
to	O
evaluate	O
his	O
progress.	O
He	O
was	O
afebrile	O
at	O
the	O
time	O
of	O
discharge	O
with	O
improvement	O
___	O
his	O
abscess	O
#	O
DM2:	O
The	O
patient's	O
last	O
HbA1c	O
on	O
___	O
was	O
6.9.	O
He	O
should	O
continue	O
sliding	O
scale	O
insulin	O
at	O
rehab.	O
His	O
PCP	O
should	O
followup	O
whether	O
any	O
other	O
agents	O
should	O
be	O
used	O
___	O
the	O
future.	O
#	O
Anemia	O
-	O
The	O
patient's	O
baseline	O
HCT	O
is	O
approx	O
30.	O
He	O
initially	O
had	O
a	O
decrease	O
of	O
his	O
HCT,	O
and	O
CT	O
scans	O
did	O
not	O
show	O
evidence	O
of	O
RP	O
bleed.	O
It	O
was	O
thought	O
to	O
be	O
likely	O
dilutional.	O
He	O
received	O
multiple	O
blood	O
tranfusions	O
during	O
this	O
hospitalizaiton.	O
Prior	O
to	O
inital	O
planned	O
discharge	O
to	O
rehab,	O
he	O
developed	O
bilateral	O
psoas	O
hematomas	O
with	O
a	O
decreasing	O
hematocrit.	O
His	O
anticoagulation	O
was	O
stopped	O
due	O
to	O
the	O
decreased	O
HCT	O
and	O
hypotension,	O
and	O
he	O
was	O
given	O
a	O
unit	O
of	O
blood	O
___	O
the	O
CCU.	O
His	O
HCT	O
stablized,	O
and	O
prior	O
to	O
discharge	O
was	O
at	O
his	O
baseline.	O
He	O
also	O
developed	O
blood	O
clots	O
___	O
the	O
urine	O
earlier	O
___	O
his	O
hospitalization.	O
He	O
had	O
bladder	O
irrigation	O
with	O
improvement.	O
At	O
the	O
time	O
of	O
discharge,	O
he	O
had	O
no	O
active	O
bleeding	O
___	O
his	O
urine.	O
He	O
was	O
guaiac	O
negative	O
during	O
his	O
hospitalization.	O
#	O
Peripheral	O
Arterial	O
Disease:	O
The	O
patient	O
was	O
admitted	O
for	O
___	O
for	O
left	O
groin	O
abcess	O
x	O
___	O
s/p	O
fem-pop	O
bypass	O
___.	O
He	O
had	O
an	O
I&D,	O
and	O
received	O
antibiotics	O
during	O
this	O
hospitalization.	O
He	O
received	O
a	O
14	O
day	O
course	O
of	O
Cefazolin	O
with	O
improvement.	O
At	O
discharge,	O
he	O
was	O
afebrile,	O
and	O
his	O
groin	O
looked	O
good.	O
He	O
will	O
need	O
continued	O
wound	O
care	O
and	O
followup	O
with	O
Dr.	O
___.	O
#	O
Hematuria	O
-	O
The	O
patient	O
had	O
difficulty	O
urinating	O
initially.	O
The	O
bladder	O
scan	O
showed	O
elevated	O
PVR,	O
though	O
likely	O
___	O
anasarca.	O
Urology	O
placed	O
a	O
foley	O
___	O
secondary	O
to	O
massive	O
edema.	O
There	O
were	O
clots	O
noted	O
___,	O
and	O
foley	O
was	O
replaced	O
and	O
he	O
was	O
started	O
on	O
CBI,	O
with	O
resolution	O
of	O
clots.	O
Now	O
that	O
he	O
is	O
off	O
anticoagulation,	O
his	O
hematuria	O
has	O
resolved.	O
He	O
will	O
be	O
discharged	O
with	O
a	O
foley,	O
and	O
that	O
should	O
eventually	O
be	O
removed	O
while	O
___	O
rheab.	O
#	O
Hyperlipidemia:	O
The	O
patient	O
will	O
continue	O
rosuvastatin.	O
His	O
lipid	O
panel	O
showed	O
HDL	O
29	O
and	O
LDL	O
41.	O
#.	O
CODE:	O
DNR/DNI	O
confirmed	O
with	O
patient	O
and	O
wife/HCP	O
#.	O
Communication:	O
wife	O
and	O
___	O
___	O
#.	O
Dispo:	O
The	O
patient	O
will	O
be	O
transferred	O
to	O
___	O
___.	O
He	O
will	O
be	O
discharged	O
with	O
a	O
foley	O
catheter	O
which	O
should	O
be	O
removed	O
after	O
bladder	O
training.	O
He	O
will	O
need	O
twice	O
weekly	O
electrolyte	O
monitoring	O
to	O
evaluate	O
his	O
kidney	O
function	O
and	O
potassium	O
levels.	O
He	O
should	O
also	O
have	O
twice	O
weekly	O
hematocrit	O
checks.	O
His	O
goal	O
I/O	O
should	O
be	O
even	O
to	O
negative	O
500	O
cc	O
daily	O
and	O
lasix	O
titration	O
accordingly.	O
Medications	O
on	O
Admission:	O
(on	O
transfer	O
from	O
rehab):	O
albuterol	O
nebulizer	O
Morphine	O
___	O
IV	O
Q6H	O
Doccusate	O
BID	O
Pantoprozole	O
40	O
daily	O
Fluticasone	O
Salmeterol	O
100/50	O
BID	O
Rosuvastatin	O
10	O
mg	O
Hydralazine	O
25	O
Q8H	O
Spirolactone	O
25	O
PO	O
daily	O
Insulin	O
lantus	O
10	O
units	O
+ss	O
Nafcillin	O
2	O
g	O
IV	O
Q6H	O
Ipratropium	O
bromide	O
neb	O
Metoprolol	O
50	O
bid	O
Discharge	O
Disposition:	O
Extended	O
Care	O
Facility:	O
___	O
Discharge	O
Diagnosis:	O
Primary	O
Diagnosis:	O
Left	O
Femoral	O
Abscess	O
Acute	O
on	O
Chronic	O
Systolic	O
Heart	O
Failure	O
Urinary	B-Urinary_tract_infection
Tract	B-Urinary_tract_infection
Infection	B-Urinary_tract_infection
Acute	O
Kidney	O
Injury	O
Anemia	O
Bilateral	O
Psoas	O
Hematomas	O
Secondary	O
Diagnosis:	O
Diabetes	O
Type	O
2	O
Hypertension	O
Atrial	O
Fibrillation	O
Coronary	O
Artery	O
Disease	O
Peripheral	O
Arterial	O
Disease	O
Discharge	O
Condition:	O
stable,	O
hematocrit	O
stable,	O
blood	O
pressure	O
stable,	O
rate	O
controlled,	O
on	O
room	O
air	O
Discharge	O
Instructions:	O
You	O
were	O
admitted	O
to	O
the	O
hospital	O
for	O
a	O
left	O
groin	O
abscess.	O
You	O
were	O
found	O
to	O
be	O
severely	O
fluid	O
overloaded	O
because	O
you	O
had	O
not	O
been	O
taking	O
your	O
lasix.	O
You	O
were	O
___	O
the	O
ICU	O
to	O
have	O
hemodialysis	O
to	O
remove	O
fluid.	O
You	O
had	O
approximately	O
___	O
liters	O
of	O
fluid	O
removal	O
while	O
you	O
were	O
___	O
the	O
hospital.	O
You	O
also	O
developed	O
a	O
urinary	B-Urinary_tract_infection
tract	B-Urinary_tract_infection
infection	B-Urinary_tract_infection
for	O
which	O
you	O
were	O
treated	O
with	O
antibiotics.	O
You	O
had	O
a	O
prolonged	O
hospital	O
course,	O
with	O
complications,	O
but	O
at	O
the	O
time	O
of	O
discharge,	O
you	O
were	O
felt	O
safe	O
to	O
go	O
to	O
rehab	O
for	O
aggressive,	O
___	O
rehabilitation.	O
You	O
will	O
no	O
longer	O
be	O
on	O
anticoagulation	O
for	O
your	O
atrial	O
fibrillation	O
given	O
your	O
spontanenous	O
bleeding	O
into	O
your	O
abdomen.	O
You	O
will	O
only	O
continue	O
aspirin.	O
Please	O
take	O
all	O
medications	O
as	O
prescribed.	O
Please	O
keep	O
all	O
scheduled	O
appointments.	O
If	O
you	O
develop	O
any	O
of	O
the	O
following	O
concerning	O
symptoms,	O
please	O
call	O
your	O
PCP	O
or	O
go	O
to	O
the	O
ED:	O
Fevers,	O
chills,	O
chest	O
pain,	O
shortness	O
of	O
breath,	O
worsening	O
leg	O
swelling,	O
blood	B-Lower_gastrointestinal_haemorrhage
___	O
the	O
stool.	B-Lower_gastrointestinal_haemorrhage
Followup	O
Instructions:	O
___	O

